{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:00:19Z","timestamp":1793721619243,"version":"4.6.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NPB","award":["13-246B"],"award-info":[{"award-number":["13-246B"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.04.102","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T14:57:43Z","timestamp":1431615463000},"page":"3065-3072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: Current status and future direction"],"prefix":"10.1016","volume":"33","author":[{"given":"Gourapura J.","family":"Renukaradhya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Jin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay G.","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Lager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.04.102_bib0450","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/molbev\/msi089","article-title":"The origin and evolution of porcine reproductive and respiratory syndrome viruses","volume":"22","author":"Hanada","year":"2005","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0455","doi-asserted-by":"crossref","first-page":"8700","DOI":"10.1128\/JVI.02551-09","article-title":"Phylogeny-based evolutionary, demographical, and geographical dissection of North American type 2 porcine reproductive and respiratory syndrome viruses","volume":"84","author":"Shi","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0460","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.virusres.2010.08.015","article-title":"The ever-expanding diversity of porcine reproductive and respiratory syndrome virus","volume":"154","author":"Murtaugh","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0465","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0378-1135(00)00196-6","article-title":"Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development","volume":"74","author":"Meng","year":"2000","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0470","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virusres.2010.07.020","article-title":"Novel strategies and approaches to develop the next generation of vaccines against porcine reproductive and respiratory syndrome virus (PRRSV)","volume":"154","author":"Huang","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(01)79001-3","article-title":"Neutralizing antiviral antibody responses","volume":"79","author":"Zinkernagel","year":"2001","journal-title":"Adv Immunol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0480","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1128\/JVI.71.5.3840-3852.1997","article-title":"Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process","volume":"71","author":"Hammond","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0485","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/13550289909022003","article-title":"Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice","volume":"5","author":"Chen","year":"1999","journal-title":"J Neurovirol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0490","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-1135(03)00157-3","article-title":"Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines","volume":"95","author":"Labarque","year":"2003","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0495","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1051\/vetres\/2009046","article-title":"Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies","volume":"40","author":"Vanhee","year":"2009","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/viro.2002.1612","article-title":"Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity","volume":"302","author":"Osorio","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0505","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/CVI.00304-06","article-title":"Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent","volume":"14","author":"Lopez","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0510","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.vetimm.2004.09.005","article-title":"Role of neutralizing antibodies in PRRSV protective immunity","volume":"102","author":"Lopez","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0515","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1439-0450.2006.00965.x","article-title":"Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows","volume":"53","author":"Papatsiros","year":"2006","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0520","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vetmic.2007.02.009","article-title":"Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge","volume":"123","author":"Zuckermann","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0525","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vetmic.2004.05.006","article-title":"The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs","volume":"102","author":"Nilubol","year":"2004","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0530","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/vr.161.24.809","article-title":"Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV","volume":"161","author":"Scortti","year":"2007","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0535","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/vim.2005.18.381","article-title":"Porcine reproductive and respiratory syndrome (PRRS) virus-specific interferon-gamma(+) T-cell responses after PRRS virus infection or vaccination with an inactivated PRRS vaccine","volume":"18","author":"Piras","year":"2005","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0540","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/088282404322875430","article-title":"Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells","volume":"17","author":"Bassaganya-Riera","year":"2004","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0545","doi-asserted-by":"crossref","first-page":"e51794","DOI":"10.1371\/journal.pone.0051794","article-title":"Biodegradable nanoparticle-entrapped vaccine induces cross-protective immune response against a virulent heterologous respiratory viral infection in pigs","volume":"7","author":"Dwivedi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0550","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetmic.2013.04.029","article-title":"PLGA nanoparticle entrapped killed porcine reproductive and respiratory syndrome virus vaccine helps in viral clearance in pigs","volume":"166","author":"Dwivedi","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0555","first-page":"679","article-title":"Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs","volume":"9","author":"Binjawadagi","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0560","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/978-0-387-33012-9_81","article-title":"Efficacy of an inactivated PRRSV vaccine: induction of virus-neutralizing antibodies and partial virological protection upon challenge","volume":"581","author":"Misinzo","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0565","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.theriogenology.2012.06.015","article-title":"Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge","volume":"78","author":"Karniychuk","year":"2012","journal-title":"Theriogenology"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0570","first-page":"63","article-title":"Biodegradable polymer microspheres as vaccine adjuvants and delivery systems","volume":"92","author":"Gupta","year":"1998","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0575","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.7809629","article-title":"A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules","volume":"267","author":"Kovacsovics-Bankowski","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0580","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nmat2960","article-title":"Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses","volume":"10","author":"Moon","year":"2011","journal-title":"Nat Mater"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0585","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0590","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/eji.200737169","article-title":"Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity","volume":"37","author":"Heit","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0595","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0600","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.4049\/jimmunol.1002084","article-title":"CD8-dendritic cells and macrophages cross-present poly(d,l-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo","volume":"187","author":"Schliehe","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0605","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/jbm.a.31019","article-title":"Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and Toll-like receptor ligand monophosphoryl lipid A in poly(d,l-lactic-co-glycolic acid) nanoparticles","volume":"81","author":"Hamdy","year":"2007","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0610","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0168-3659(00)00330-8","article-title":"A novel bioadhesive intranasal delivery system for inactivated influenza vaccines","volume":"70","author":"Singh","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0615","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0034-5288(02)00180-7","article-title":"Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice","volume":"74","author":"Shephard","year":"2003","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0620","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/02652040802211709","article-title":"Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination","volume":"26","author":"Nayak","year":"2009","journal-title":"J Microencapsul"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0625","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijpharm.2009.06.006","article-title":"Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses","volume":"379","author":"Thomas","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0630","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.nano.2010.02.002","article-title":"In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems","volume":"6","author":"Semete","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0635","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1369-7021(05)71032-4","article-title":"Nanomedicine gets clinical","volume":"8","author":"Duncan","year":"2005","journal-title":"Mater Today"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0640","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1189\/jlb.0205074","article-title":"Nanotechnology for the biologist","volume":"78","author":"McNeil","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0645","first-page":"1519","article-title":"An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination","volume":"9","author":"Binjawadagi","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0650","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jviromet.2014.05.021","article-title":"Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus","volume":"206","author":"Ren","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0655","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1016\/j.vaccine.2014.10.005","article-title":"In vivo targeting of porcine reproductive and respiratory syndrome virus antigen through porcine DC-SIGN to dendritic cells elicits antigen-specific CD4T cell immunity in pigs","volume":"32","author":"Subramaniam","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0660","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/j.vaccine.2014.04.083","article-title":"Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5","volume":"32","author":"Lee","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0665","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0042-6822(95)80030-1","article-title":"Characterization of proteins encoded by ORFs 2 to 7 of Lelystad virus","volume":"206","author":"Meulenberg","year":"1995","journal-title":"Virology"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2015.04.102_bib0670","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1099\/0022-1317-79-5-961","article-title":"The molecular biology of arteriviruses","volume":"79","author":"Snijder","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0675","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.virusres.2005.06.014","article-title":"The 2b protein as a minor structural component of PRRSV","volume":"114","author":"Wu","year":"2005","journal-title":"Virus Res"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2015.04.102_bib0680","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1099\/0022-1317-77-6-1271","article-title":"Genetic variation in porcine reproductive and respiratory syndrome virus isolates in the midwestern United States","volume":"77","author":"Kapur","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0685","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/BF01322671","article-title":"Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus","volume":"140","author":"Murtaugh","year":"1995","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0690","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1016\/j.vaccine.2009.04.022","article-title":"Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology","volume":"27","author":"Kimman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0695","doi-asserted-by":"crossref","first-page":"e1000730","DOI":"10.1371\/journal.ppat.1000730","article-title":"The M\/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner","volume":"6","author":"Van Breedam","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0700","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s007050050662","article-title":"Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates","volume":"145","author":"Dea","year":"2000","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0705","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/viro.1996.0356","article-title":"Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus","volume":"221","author":"Mardassi","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0710","doi-asserted-by":"crossref","first-page":"12495","DOI":"10.1128\/JVI.79.19.12495-12506.2005","article-title":"Envelope protein requirements for the assembly of infectious virions of porcine reproductive and respiratory syndrome virus","volume":"79","author":"Wissink","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0715","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/08820139.2011.614306","article-title":"Vaccination of mice with ORF5 plasmid DNA of PRRSV; enhanced effects by co-immunizing with porcine IL-15","volume":"41","author":"Li","year":"2012","journal-title":"Immunol Invest"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0720","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11262-012-0790-1","article-title":"Evaluation of a DNA vaccine candidate co-expressing GP3 and GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) with interferon alpha\/gamma in immediate and long-lasting protection against HP-PRRSV challenge","volume":"45","author":"Du","year":"2012","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0725","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/v5020663","article-title":"Predicted peptides from non-structural proteins of porcine reproductive and respiratory syndrome virus are able to induce IFN-gamma and IL-10","volume":"5","author":"Burgara-Estrella","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0730","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virusres.2012.06.024","article-title":"Location of T-cell epitopes in nonstructural proteins 9 and 10 of type-II porcine reproductive and respiratory syndrome virus","volume":"169","author":"Parida","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0735","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CVI.00365-09","article-title":"Comparative measurement of cell-mediated immune responses of swine to the M and N proteins of porcine reproductive and respiratory syndrome virus","volume":"17","author":"Jeong","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0740","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1743-422X-9-141","article-title":"Identification of nonessential regions of the nsp2 protein of an attenuated vaccine strain (HuN4-F112) of highly pathogenic porcine reproductive and respiratory syndrome virus for replication in marc-145 cell","volume":"9","author":"Xu","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0745","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4149\/av_2011_02_139","article-title":"Immunogenicity of the envelope GP3 protein of porcine reproductive and respiratory syndrome virus displayed on baculovirus","volume":"55","author":"Wang","year":"2011","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0750","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1007931322271","article-title":"Baculovirus expression of proteins of porcine reproductive and respiratory syndrome virus strain Olot\/91. Involvement of ORF3 and ORF5 proteins in protection","volume":"14","author":"Plana Duran","year":"1997","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0755","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetimm.2011.01.002","article-title":"Evaluation of the immunogenicity of a transgenic tobacco plant expressing the recombinant fusion protein of GP5 of porcine reproductive and respiratory syndrome virus and B subunit of Escherichia coli heat-labile enterotoxin in pigs","volume":"140","author":"Chia","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0760","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.vetimm.2009.12.003","article-title":"Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant","volume":"135","author":"Chia","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0765","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/pbi.12015","article-title":"Oral immunogenicity of porcine reproductive and respiratory syndrome virus antigen expressed in transgenic banana","volume":"11","author":"Chan","year":"2013","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0770","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.vaccine.2012.01.059","article-title":"Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV)","volume":"30","author":"Hu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0775","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00425-011-1523-8","article-title":"Expression of the nucleocapsid protein of porcine reproductive and respiratory syndrome virus in soybean seed yields an immunogenic antigenic protein","volume":"235","author":"Vimolmangkang","year":"2012","journal-title":"Planta"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0780","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jviromet.2011.02.001","article-title":"Generation and immunogenicity of transgenic potato expressing the GP5 protein of porcine reproductive and respiratory syndrome virus","volume":"173","author":"Chen","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0785","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00705-002-0943-y","article-title":"Adenoviral-expressed GP5 of porcine respiratory and reproductive syndrome virus differs in its cellular maturation from the authentic viral protein but maintains known biological functions","volume":"148","author":"Gagnon","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0790","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.virusres.2008.04.016","article-title":"Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and\/or GP4 of PRRS virus","volume":"136","author":"Jiang","year":"2008","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0795","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11262-007-0161-5","article-title":"Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV)","volume":"35","author":"Zheng","year":"2007","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0800","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1016\/j.vaccine.2007.03.010","article-title":"Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5\/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18","volume":"25","author":"Shen","year":"2007","journal-title":"Vaccine"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2015.04.102_bib0805","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1099\/0022-1317-79-5-989","article-title":"Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus","volume":"79","author":"Pirzadeh","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0810","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11262-005-5839-y","article-title":"Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus","volume":"32","author":"Fang","year":"2006","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0815","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.vaccine.2009.01.098","article-title":"Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene","volume":"27","author":"Li","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0820","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.vetimm.2006.05.001","article-title":"Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice","volume":"113","author":"Jiang","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0825","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10529-008-9905-0","article-title":"A suicidal DNA vaccine co-expressing two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus antigens induce protective responses","volume":"31","author":"Jiang","year":"2009","journal-title":"Biotechnol Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.102_bib0830","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4142\/jvs.2014.15.1.99","article-title":"Positive inductive effect of porcine IL-2 and IL-4 on virus-speci fi c immune responses induced by PRRSV-ORF5 DNA vaccine in swine","volume":"15","author":"Tang","year":"2013","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0835","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.vetimm.2013.05.008","article-title":"CTLA4 mediated targeting enhances immunogenicity against PRRSV in a DNA prime\/killed virus boost strategy","volume":"154","author":"Wang","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0840","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.rvsc.2012.09.011","article-title":"Positive inductive effect of IL-18 on virus-specific immune responses induced by PRRSV-GP5 DNA vaccine in swine","volume":"94","author":"Zhang","year":"2013","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0845","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.3390\/ijms13055715","article-title":"Immune responses in pigs induced by recombinant DNA vaccine co-expressing Swine IL-18 and membrane protein of porcine reproductive and respiratory syndrome virus","volume":"13","author":"Zhang","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0850","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/vim.2012.0041","article-title":"Immunization with DNA vaccines containing porcine reproductive and respiratory syndrome virus open reading frames 5, 6, and 7 may be related to the exacerbation of clinical disease after an experimental challenge","volume":"26","author":"Diaz","year":"2013","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0855","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.vetmic.2010.05.007","article-title":"The immunogenicity of DNA constructs co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus conjugated by GPGP linker in pigs","volume":"146","author":"Chia","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0860","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(03)00009-6","article-title":"Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination","volume":"309","author":"Meier","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0865","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.intimp.2007.09.012","article-title":"Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo","volume":"7","author":"Zhang","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0870","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.vaccine.2006.07.032","article-title":"Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus","volume":"25","author":"Jiang","year":"2007","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2015.04.102_bib0875","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/j.vaccine.2014.04.083","article-title":"Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5","volume":"32","author":"Lee","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetmic.2007.03.007","article-title":"Effect of genotypic and biotypic differences among PRRS viruses on the serologic assessment of pigs for virus infection","volume":"123","author":"Kim","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0885","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.vetimm.2004.09.021","article-title":"Immune responses of swine following DNA immunization with plasmids encoding porcine reproductive and respiratory syndrome virus ORFs 5 and 7, and porcine IL-2 and IFNgamma","volume":"102","author":"Xue","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.04.102_bib0890","doi-asserted-by":"crossref","first-page":"e91386","DOI":"10.1371\/journal.pone.0091386","article-title":"Boosting in planta production of antigens derived from the porcine reproductive and respiratory syndrome virus (PRRSV) and subsequent evaluation of their immunogenicity","volume":"9","author":"Piron","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500612X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500612X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T23:55:15Z","timestamp":1717890915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1500612X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":89,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X1500612X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.102","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: Current status and future direction","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}